Upregulation of mitochondrial fusion as potential cardioprotective strategies against trastuzumab-induced cardiotoxicity in rats

被引：0
|
作者：
Maneechote, C. [1 ]
Khuanjing, T. [1 ]
Ongnok, B. [1 ]
Arinno, A. [1 ]
Prathumsap, N. [1 ]
Chunchai, T. [1 ]
Arunsak, B. [1 ]
Kerdphoo, S. [1 ]
Chattipakorn, S. C. [1 ]
Chattipakorn, N. [1 ]
机构：
[1] Chiang Mai Univ, Cardiac Electrophysiol Res & Training Ctr, Fac Med, Chiang Mai, Thailand
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] TRASTUZUMAB-INDUCED CARDIOTOXICITY: CAN BIOMARKERS AID DIAGNOSIS?
    Harbinson, M.
    Forrest, P.
    Clayton, A.
    Campbell, M.
    Bell, D.
    HEART, 2012, 98
  • [22] Anthracycline- and trastuzumab-induced cardiotoxicity: a retrospective study
    Hamirani, Yasmin
    Fanous, Ibrahim
    Kramer, Christopher M.
    Wong, Andrew
    Salerno, Michael
    Dillon, Patrick
    MEDICAL ONCOLOGY, 2016, 33 (07)
  • [23] Protective Effect of Curcumin, Chrysin and Thymoquinone Injection on Trastuzumab-Induced Cardiotoxicity via Mitochondrial Protection
    Shirmard, Leila Rezaie
    Shabani, Mohammad
    Moghadam, Amin Ashena
    Zamani, Nasim
    Ghanbari, Hadi
    Salimi, Ahmad
    CARDIOVASCULAR TOXICOLOGY, 2022, 22 (07) : 663 - 675
  • [24] Protective Effect of Curcumin, Chrysin and Thymoquinone Injection on Trastuzumab-Induced Cardiotoxicity via Mitochondrial Protection
    Leila Rezaie Shirmard
    Mohammad Shabani
    Amin Ashena Moghadam
    Nasim Zamani
    Hadi Ghanbari
    Ahmad Salimi
    Cardiovascular Toxicology, 2022, 22 : 663 - 675
  • [25] Impact of Trastuzumab-Induced Cardiotoxicity and Subsequent Trastuzumab Interruption on Breast Cancer Outcome
    Yu, Anthony F.
    Yadav, Nandini U.
    Manrique, Carlos R.
    Thaler, Howard T.
    Hudis, Clifford A.
    Dang, Chau T.
    Steingart, Richard M.
    CIRCULATION, 2013, 128 (22)
  • [26] Doxorubicin-induced and trastuzumab-induced cardiotoxicity in mice is not prevented by metoprolol
    Nicol, Martin
    Sadoune, Malha
    Polidano, Evelyne
    Launay, Jean Marie
    Samuel, Jane Lise
    Azibani, Feriel
    Cohen-Solal, Alain
    ESC HEART FAILURE, 2021, 8 (02): : 928 - 937
  • [27] Detection of Subclinical Trastuzumab-Induced Cardiotoxicity in Patients with Breast Cancer
    Higuchi dos Santos, Marilia Harumi
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2013, 101 (01) : 2 - 3
  • [28] Is trastuzumab-induced cardiotoxicity involved in onco-cardiology outcome?
    Alonso Gordoa, Teresa
    Angel Garcia-Saenz, Jose
    Rodriguez Moreno, Juan Francisco
    Hernandez Perez, Francisco Jose
    Diaz-Rubio, Eduardo
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (07): : 451 - 459
  • [29] Prevalence of trastuzumab-induced cardiotoxicity in a real-world setting
    Calvillo-Arguelles, O.
    Flores-Diaz, D.
    Gonzalez-Serrano, J-P
    Lopez-Rojas, A.
    Mendoza-Galindo, L.
    Matus-Santos, J-A
    Reynoso-Noveron, N.
    Cabrera-Galeana, P.
    Bargallo-Rochaand, E.
    Arce-Salinas, C.
    CANCER RESEARCH, 2019, 79 (04)
  • [30] Factors for time to trastuzumab-induced cardiotoxicity in breast cancer patients
    Mi Hyung Lee
    Jeong Yee
    Young Ju Kim
    Jin Young Moon
    Joo Hee Kim
    Sandy Jeong Rhie
    Hye Sun Gwak
    Medical Oncology, 2017, 34
12345